NeuroCardio Baby Research Outpatient Clinic: Study on the Neurodevelopment of Infants With Congenital Heart Disease in Brazil

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-16

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this randomized clinical trial is to test the effectiveness of a low-cost hybrid remotely monitored parent-mediated and clinic-based multidisciplinary early intervention (EI) for low-income infants with CHD in Brazil. The intervention protocols will be administered according to age modules, families will be monitored weekly. High risk infants also receive supplemental clinic-based interventions according to developmental needs. Controls will receive standard of care and access to early child development and nutrition practices information from the Brazilian Ministry of Health. All infants will be evaluated at within a 42-month follow-up research outpatient clinic, called NeuroCardio Baby at Santo Antonio Pediatric Hospital, of the Santa Casa de Misericordia Hospital Complex, and affiliated with The Cardiology Institute-University Foundation of Cardiology (IC-FUC), Porto Alegre, Brazil.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predictive Value of Neurovascular Coupling in Infants With COngenital Heart Disease

NCT06190210

Congenital Heart Disease Neurodevelopmental Disorders Electroencephalography +2 more

RECRUITING

Assessing Neurodevelopment in Congenital Heart Disease.

NCT02996630

Congenital Heart Disease

UNKNOWN NA

Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease

NCT01291797

Congenital Heart Disease

TERMINATED

Different Intervention Models of Premature Infants Based on the ICF Biopsychosocial Model

NCT05989438

Prematurity

RECRUITING NA

Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome

NCT00713635

Congenital Heart Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this randomized clinical trial is to develop low-cost hybrid remotely monitored parent-mediated multidisciplinary early intervention (EI) protocols for infants with CHD in Brazil. The protocols will be conducted via parents at home according to age modules (0- 3m, 3-6m, 6-9m, and 9-12m), and families will be monitored by clinical researchers weekly. High risk infants will receive supplemental EI services at the clinic according to developmental needs. Infants will receive outcome evaluations within a 42-month follow-up clinic. The aim of this study is to prevent or reduce neurodevelopmental sequelae and developmental delays associated with CHD. Participants in the intervention group receive multidisciplinary EIs in Nutrition (including breastfeeding support), Speech and Language Therapy for tube feeding transition, feeding readiness, and language and motor development and early stimulation for global development in cognitive, language and motor skills according to age milestones. Premature infants will receive age-corrected protocols and evaluations. Caregivers will receive psychological and protocol administration support. The control group receives basic child development, nutrition, and breastfeeding information provided by the Brazilian Ministry of Health, in addition to standard of care cardiac pediatric follow-up visits. Neurodevelopment is assessed with the Brazilian Version of Bayley Developmental Scale for Infants and Toddlers (3rd edition) in both groups, at 6, 12, 24, and 36-42 months. Nutritional outcomes, such as ml of breastmilk drown by mothers, and infant weight and length are measured. The study will compare the developmental outcome scores and parental quality of life scores of the intervention and control groups during the intervention (6 and 12months) and at 1 and 2 years follow up. We believe that infants with CHD who receive monitoring and early multidisciplinary interventions in the first year of life have better neurodevelopmental outcomes than infants who do not receive early multidisciplinary care. In Brazil, access to EI services is extremely limited to urban centers and higher income families. Infants from low-income backgrounds and rural settings are likely to be left without services during early childhood. Our remote, low-cost intervention aims at increasing access to EI for Brazilian infants with CHD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Heart Disease Child Development Early Intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Prospective Multicentric single-blinded, Two-arm Randomized Clinical Trial

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Assessors blinded to the allocation of participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Remotely monitored parent-mediated hybrid home and clinic based multidisciplinary Early Intervention protocols.

Group Type EXPERIMENTAL

Remotely monitored parent-mediated hybrid home and clinic based multidisciplinary Early Intervention protocols.

Intervention Type BEHAVIORAL

* Parents receive manualized protocols, instructional videos, and toy and material kits to administer EIs at home.
* New modules are provided according to infant age or stage of intervention during the length of brief interventions or 12-months.
* The families will be monitored by clinical researchers weekly. -High risk infants will receive supplemental EI services at the clinic according to developmental needs.
* Infants will receive outcome evaluations within a 42-month follow-up clinic.

Control Group - Standart of Care

* The control group receives basic guidelines on child development, nutrition, and breastfeeding provided by the Brazilian Ministry of Health, in addition to standard of care cardiac pediatric follow-up visits.
* Infants will receive outcome developmental evaluations within a 42-month follow-up clinic.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remotely monitored parent-mediated hybrid home and clinic based multidisciplinary Early Intervention protocols.

* Parents receive manualized protocols, instructional videos, and toy and material kits to administer EIs at home.
* New modules are provided according to infant age or stage of intervention during the length of brief interventions or 12-months.
* The families will be monitored by clinical researchers weekly. -High risk infants will receive supplemental EI services at the clinic according to developmental needs.
* Infants will receive outcome evaluations within a 42-month follow-up clinic.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women with a fetal diagnosis of CHD
* Child up to two months diagnosed with CHD
* Signature of the electronic free and informed consent form by those parents or legal guardians.

Exclusion Criteria

* Psychiatric or neurocognitive condition that prevents obtaining reliable clinical data (defined by the clinical judgment of the investigators)
* Inability to read by parents or legal guardians.

Maximum Eligible Age

2 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No